TRP Channel
TRP (transient receptor potential) channels are a family of cation channels that sense various external and celluar signals such as mechanical stress, temperature, cellular messengers and exogenous chemicals. It is implicated in vascular tone , neurological disorders, kidney diseases, hypomagnesemia and hypocalcemia etc.
Products Related to TRP Channel(184)
- GC69928SOR-C13 TFAPurity: >99.00%
SOR-C13 TFA is a carboxy-terminal truncated peptide and a high-affinity TRPV6 antagonist with an IC50 value of 14 nM. TRPV6 is a non-voltage-gated calcium channel that is associated with malignant tumors and poor prognosis in breast cancer. SOR-C13 TFA has anti-cancer activity.
- GC70066TRPC6-IN-3CAS: 2311863-36-0Purity: >99.00%
TRPC6-IN-3 (compound 17) is an orally effective inhibitor of transient receptor potential cation channel subfamily C member 6 (TRPC6). TRPC6-IN-3 can not only regulate intracellular calcium concentration, but also modulate membrane potential by regulating cation flux including calcium and sodium ions. TRPC6-IN-3 can be used for research in the respiratory system.
- GC70067TRPV1 antagonist 3Purity: >99.00%
TRPV1 antagonist 3 (Compound 7q) is an effective TRPV1 antagonist with an IC50 value of 2.66 nM against capsaicin. It has mode selectivity and good oral bioavailability (F = 60%), and can penetrate the blood-brain barrier.
- GC70305ElismetrepCAS: 1400699-64-0Purity: >99.00%
Elismetrep (MT-8554) is an oral active TRPM8 inhibitor, and can be used for study of analgesic.
- GC70321TRPV1 antagonist 5CAS: 878811-00-8
TRPV1 antagonist 5 (compound 1) is a potent TRPV1 antagonist.
- GC70676Tivanisiran sodiumCAS: 1848239-71-3Purity: >92.00%
Tivanisiran sodium is a small interfering RNA (siRNA) drug with topical ophthalmic activity that targets and induces the degradation of TRPV1 (Transient Receptor Potential Cation Channel Subfamily V Member 1) mRNA.
- GC71419TRPV2-selective blocker 1CAS: 2242724-49-6Purity: >99.50%
TRPV2-selective blocker 1 (compound IV2-1) is a selective TRPV2 channel blocker with an IC50 of 6.3 μM.
- GC73042(1S,2S)-ML-SI3CAS: 2563870-87-9Purity: >99.00%
(1S,2S)-ML-SI3 is a trans-isomer of ML-SI3 that targets all three isoforms of TRPML.
- GC73075(rel)-ML-SI3CAS: 2108567-79-7Purity: >99.00%
(rel)-ML-SI3 is one of the active ingredients of ML-SI3 (another component is (cis)-ML-SI3) that targets three isoforms of TRPML.
- GC74418Wasabi Receptor Toxin TFAPurity: >99.00%
Wasabi Receptor Toxin TFA (WaTx TFA) is the TFA salt form of Wasabi Receptor Toxin.
- GC79522TRPA1 agonist-3CAS: 3083086-77-2Purity: >99.50%
TRPA1 agonist-3 is a selective and orally active TRPA1 agonist, with EC 50 values of 50.05 μM and 314.04 μM for human and mouse TRPA1, respectively.
- GC79523IndazapyroxametCAS: 1689545-27-4Purity: >98%
Indazapyroxamet is an orally active insect TRPV channel (Nan/Iav subunit) modulator and insecticide.
- GC79525TRPM3-IN-1CAS: 2776193-88-3Purity: >98.00%
TRPM3-IN-1 (compound 124) is an inhibitor of TRPM3 with an IC 50 value <1 µM.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC69928 | SOR-C13 TFA | - | >99.00% | |
SOR-C13 TFA is a carboxy-terminal truncated peptide and a high-affinity TRPV6 antagonist with an IC50 value of 14 nM. TRPV6 is a non-voltage-gated calcium channel that is associated with malignant tumors and poor prognosis in breast cancer. SOR-C13 TFA has anti-cancer activity. | ||||
| GC70066 | TRPC6-IN-3 | 2311863-36-0 | >99.00% | |
TRPC6-IN-3 (compound 17) is an orally effective inhibitor of transient receptor potential cation channel subfamily C member 6 (TRPC6). TRPC6-IN-3 can not only regulate intracellular calcium concentration, but also modulate membrane potential by regulating cation flux including calcium and sodium ions. TRPC6-IN-3 can be used for research in the respiratory system. | ||||
| GC70067 | TRPV1 antagonist 3 | - | >99.00% | |
TRPV1 antagonist 3 (Compound 7q) is an effective TRPV1 antagonist with an IC50 value of 2.66 nM against capsaicin. It has mode selectivity and good oral bioavailability (F = 60%), and can penetrate the blood-brain barrier. | ||||
| GC70305 | Elismetrep | 1400699-64-0 | >99.00% | |
Elismetrep (MT-8554) is an oral active TRPM8 inhibitor, and can be used for study of analgesic. | ||||
| GC70321 | TRPV1 antagonist 5 | 878811-00-8 | - | |
TRPV1 antagonist 5 (compound 1) is a potent TRPV1 antagonist. | ||||
| GC70412 | GDC-0334 | 1984824-54-5 | - | |
GDC-0334 is a selective TRPA1 antagonist. | ||||
| GC70676 | Tivanisiran sodium | 1848239-71-3 | >92.00% | |
Tivanisiran sodium is a small interfering RNA (siRNA) drug with topical ophthalmic activity that targets and induces the degradation of TRPV1 (Transient Receptor Potential Cation Channel Subfamily V Member 1) mRNA. | ||||
| GC70794 | Palvanil | 69693-13-6 | - | |
Palvanil is a Capsaicin analogue, shows strong desensitizing capability against the TRPV1 receptor. | ||||
| GC71398 | GDC-6599 | 2376824-99-4 | >99.00% | |
GDC-6599 (Example 8) is an orally active TRPA1 inhibitor. | ||||
| GC71419 | TRPV2-selective blocker 1 | 2242724-49-6 | >99.50% | |
TRPV2-selective blocker 1 (compound IV2-1) is a selective TRPV2 channel blocker with an IC50 of 6.3 μM. | ||||
| GC72821 | RN-9893 | 1803003-68-0 | >99.00% | |
RN-9893 is a potent and selective TRPV4 receptor antagonist with IC50 values of 320, 420 and 660 nM for mouse, human and rat channels, respectively. | ||||
| GC73042 | (1S,2S)-ML-SI3 | 2563870-87-9 | >99.00% | |
(1S,2S)-ML-SI3 is a trans-isomer of ML-SI3 that targets all three isoforms of TRPML. | ||||
| GC73075 | (rel)-ML-SI3 | 2108567-79-7 | >99.00% | |
(rel)-ML-SI3 is one of the active ingredients of ML-SI3 (another component is (cis)-ML-SI3) that targets three isoforms of TRPML. | ||||
| GC73917 | RN-1665 | 1803003-65-7 | >99.00% | |
RN-1665 is an orally active TRPV4 antagonist that exhibits excellent selectivity for related TRP receptors such as TRPV1, TRPV3 and TRPM8. | ||||
| GC74344 | SOR-C13 | 1187852-48-7 | >98.00% | |
SOR-C13, a carboxy-terminal truncated peptide, is a high-affinity TRPV6 antagonist with an IC50 value of 14 nM. | ||||
| GC74345 | SOR-C13 acetate | - | >98.00% | |
SOR-C13 acetate is the acetate salt form of SOR-C13. | ||||
| GC74418 | Wasabi Receptor Toxin TFA | - | >99.00% | |
Wasabi Receptor Toxin TFA (WaTx TFA) is the TFA salt form of Wasabi Receptor Toxin. | ||||
| GC79519 | SKF-96365 | 162849-90-3 | >99.50% | |
SKF-96365 is a TRPC channel antagonist and store-operated calcium entry ( SOCE ) inhibitor. | ||||
| GC79522 | TRPA1 agonist-3 | 3083086-77-2 | >99.50% | |
TRPA1 agonist-3 is a selective and orally active TRPA1 agonist, with EC 50 values of 50.05 μM and 314.04 μM for human and mouse TRPA1, respectively. | ||||
| GC79523 | Indazapyroxamet | 1689545-27-4 | >98% | |
Indazapyroxamet is an orally active insect TRPV channel (Nan/Iav subunit) modulator and insecticide. | ||||
| GC79524 | ADM 12 | 1644134-60-0 | >98.50% | |
ADM 12 is a highly selective transient receptor potential ankyrin 1 ( TRPA1 ) channel antagonist. | ||||
| GC79525 | TRPM3-IN-1 | 2776193-88-3 | >98.00% | |
TRPM3-IN-1 (compound 124) is an inhibitor of TRPM3 with an IC 50 value <1 µM. | ||||
| GC79526 | AM-0883 | - | >98.50% | |
AM-0883 is a TRPC6 (Transient receptor potential canonical 6) agonist ( hTRPC6 EC 50 = 46 nM). | ||||
| GC79527 | AMG-8562 | 1041478-78-7 | >98% | |
AMG-8562 is a selective, orally active transient receptor potential vanilloid 1 ( TRPV1 ) modulator that inhibits the activation of rat TRPV1 by Capsaicin, Anandamide and N-arachidonyldopamine, with IC 50 values of 1.75, 9.29 and 3.87 nM, respectively. | ||||
